Search Bar & Filters
Found 3 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating Basic Body Awareness Therapy BBAT compared to stretching exercises for people with fibromyalgia. The study aims to see if BBAT can better reduce pain, improve biomarkers like serotonin, dopamine, and cortisol, and enhance psychological well-being and quality of life. This clinical trial involves randomized and controlled groups and includes patients diagnosed with fibromyalgia for at least six months. Participants will be divided into two groups one receiving BBAT and the other doing stretching exercises. BBAT sessions last 90 minutes and occur twice weekly for 12 weeks, focusing on movements of daily life, massage, and self-reflection. The stretching group will perform analytic stretching of the trunk and limbs for about 45 minutes twice a week for 12 weeks. Follow-up assessments will be done up to one year after treatment. During the study, participants will be assessed with various tools including the Fibromyalgia Impact Questionnaire, Visual Analog Scale, State Trait Anxiety Inventory, and Beck Depression Inventory. Biomarkers such as serotonin and cortisol will be measured at multiple points including post-treatment and during follow-up visits at 12 weeks, 24 weeks, and one year. The study includes detailed monitoring of psychological state, pain levels, and biological markers over the full duration.
Actively Recruiting
Researchers are collecting detailed information about patients with venous thromboembolism VTE to improve understanding of this condition, especially in groups often excluded from clinical trials such as pregnant women, elderly patients, and those with severe health issues. This observational registry aims to provide data that can help reduce death rates, recurrences of blood clots, bleeding problems, and arterial events related to VTE. This study gathers clinical details about each patient, including other health conditions, and tracks the type, dose, duration, and results of antithrombotic treatments over the first three months. The registry is accessible online to assist doctors in managing complex cases by comparing patient profiles and identifying those at higher risk of complications. Participants clinical status and treatment outcomes are recorded, focusing on recurrence of VTE, bleeding events, and mortality over a three-year period. The information supports the creation of predictive scores to help healthcare providers identify patients at higher risk. The study started in 2001 and plans to continue until 2027, with ongoing data collection and follow-up.
Actively Recruiting
Researchers are studying whether ultrasound-guided alcohol sclerotherapy can reduce pelvic pain and improve quality of life in women aged 18 to 45 diagnosed with ovarian endometriomas, compared to expectant management. Endometriosis is a common condition causing chronic pelvic pain and fertility issues, with ovarian endometrioma being the most frequent form. This trial aims to clarify if sclerotherapy offers better symptom relief and quality of life improvements than simply monitoring the condition. Participants will be randomly assigned to either receive ultrasound-guided alcohol sclerotherapy, where the cyst is punctured and treated with alcohol for 15 minutes followed by a wash, or to a control group receiving expectant management with standard pain care if needed. The study will compare these groups over 6 months, focusing on pain levels, quality of life, and fertility outcomes. During the study, participants will complete pain and quality of life assessments at the start and after 6 months. They will also provide blood and urine samples for biomarker analysis and undergo tests to assess ovarian reserve. Researchers will monitor adverse events, recurrence, pregnancy rates over about 2 years, and healthcare costs. The study uses rigorous analysis methods to assess the benefits and risks of the treatment.